Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study (NCT02414438) | Clinical Trial Compass
CompletedNot Applicable
Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study
United States217 participantsStarted 2014-08
Plain-language summary
The study uses a randomized controlled study design of pediatric neurologists and developmental pediatricians and front-line (primary care) pediatricians to determine if use of FirstStepDx PLUS and Next StepDx PLUS are associated with higher clinical quality, less variability in clinical practice, and lower costs from decreased resource utilization. The Clinical Performance and Value Vignettes (CPV) used in this study simulate a clinical encounter for individuals with an atypical phenotype and clinical presentation indicative of a possible genetic disorder. We will measure the difference in combined diagnostic and treatment CPV® domain score post-intervention versus baseline comparing intervention and control groups
Who can participate
Age range99 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Provide consent to participate in the study
✓. Currently practicing board-certified physician in the following specialty areas:
✓. Pediatric neurologists
✓. Developmental pediatricians
✓. General pediatricians
✓. Have practiced as a board-certified physician for greater than 2 but less than 30 years.
✓. English-speaking
✓. Community / non-academic based practice setting
Exclusion criteria
✕. Not board certified in their respective area of care
✕. Academic-based practice
✕. Have previously used FirstStepDx PLUS and/or NextStepDx PLUS in their care delivery